Antigen doses used for challenge in mice model of asthma differently affect airway hyperresponsiveness and airway inflammation in the lungs (CROSBI ID 564558)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Bošnjak, Berislav ; Ivetić Tkalčević, Vanesa ; Perović, Daniela ; Ferenčić, Željko ; Dominis Kramarić, Miroslava ; Marković, Stribor ; Čulić, Ognjen ; Eraković, Vesna ; Hrvačić, Boška
engleski
Antigen doses used for challenge in mice model of asthma differently affect airway hyperresponsiveness and airway inflammation in the lungs
Airway inflammation (AI) and hyperresponsiveness (AHR) are two asthma hallmarks. However, the function of particular cell types, i.e. eosinophils or T-cells, in the development of AHR is still not unambigously elucidated. We hypothesized that challenge of mice with varying antigen doses could provide new insights into the complex mechanisms by which AI enhances AHR. AHR was detected only in mice challenged with larger OVA dose, indicating dependence of AHR on the antigen dose used for challenge. In contrast to AHR, accumulation of inflammatory cells was not influenced by applied antigen dose. Subsequent DNA microarray analysis revealed that larger OVA dose induces more prominent expression of macrophage chemoattractant protein 1 (MCP-1) and secreted phosphoprotein 1 (Spp1). Our results imply that AHR is more sensitive to effects of antigen dose than accumulation of inflammatory cells.
asthma; inflammation; hyperresponsiveness; ovalbumin; microarray; MCP-1; Spp1
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2005.
objavljeno
Podaci o matičnoj publikaciji
Book of abstracts of the 2005 Annual Meeting of the Croatian Immunological Society
Podaci o skupu
Annual meeting of the Croatian Immunological Society 2005
poster
29.09.2005-02.10.2005
Božava, Hrvatska